Literature DB >> 7902362

Human lymphocyte antigens (HLA) and Graves' disease in Turkey.

Y Orhan1, A Azezli, M Carin, F Aral, E Sencer, S Molvalilar.   

Abstract

To evaluate the association of HLA types with Turkish patients with Graves' disease, HLA typing, clinical findings, and thyroid antibodies were correlated. The HLA types, clinical findings (ophthalmopathy and age at onset), and thyroid stimulating hormone (TSH) receptor (TRAb) and antithyroid microsomal antibodies (MAb) were analyzed. Seventy Turkish patients with Graves' disease and 306 control subjects were assessed. Serological HLA typing was performed in HLA A, B, C, DR, and DQ loci. There was a significantly increased prevalence of HLA B8, B49, DR3, DR4, and DR10 in Graves' disease. The association of Graves' disease with HLA DR3 was found to be less strong than previously described. The HLA DR4 antigen may contribute to the predisposition of Graves' disease in Turkey. The results suggest that HLA B7, B13, DR7, DQw2, and DQw3 may confer a protective effect for Graves' disease in Turkey. Patients carrying HLA B12, B18, and B44 haplotypes had a tendency to develop the disease at a later age. The difference from the other studies may be the result of the selection of the controls; in part, of the variability in serological typing reagents; and, also, of the rather weak HLA associations with the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902362     DOI: 10.1007/bf00920242

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  30 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease.

Authors:  F C Grumet; R O Payne; J Konishi; J P Kriss
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

3.  Prediction of relapse in hyperthyroid Graves' disease.

Authors:  A M McGregor; B R Smith; R Hall; M M Petersen; M Miller; P J Dewar
Journal:  Lancet       Date:  1980-05-24       Impact factor: 79.321

4.  HLA antigens in Asian Indian patients with Graves' disease.

Authors:  N Tandon; N K Mehra; V Taneja; M C Vaidya; N Kochupillai
Journal:  Clin Endocrinol (Oxf)       Date:  1990-07       Impact factor: 3.478

5.  Graves' disease and HLA: clinical and epidemiologic associations.

Authors:  N R Farid; E Stone; G Johnson
Journal:  Clin Endocrinol (Oxf)       Date:  1980-12       Impact factor: 3.478

6.  HLA antigens in Graves' disease.

Authors:  K Bech; B Lumholtz; J Nerup; M Thomsen; P Platz; L P Ryder; A Svejgaard; K Siersbaek-Nielsen; J M Hansen; J H Larsen
Journal:  Acta Endocrinol (Copenh)       Date:  1977-11

7.  HLA in American blacks with juvenile diabetes.

Authors:  M R Neufeld; N K Maclaren; W J Riley
Journal:  N Engl J Med       Date:  1980-07-10       Impact factor: 91.245

8.  A study of human leukocyte D locus related antigens in Graves' disease.

Authors:  N R Farid; L Sampson; E P Noel; J M Barnard; R Mandeville; B Larsen; W H Marshall; N D Carter
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

9.  Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA.

Authors:  N R Farid; J M Barnard; W H Marshall; I Woolfrey; R F O'Driscoll
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

10.  Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects.

Authors:  T J Lawley; R P Hall; A S Fauci; S I Katz; M I Hamburger; M M Frank
Journal:  N Engl J Med       Date:  1981-01-22       Impact factor: 91.245

View more
  2 in total

1.  Euthyroid Graves' ophthalmopathy with negative autoantibodies.

Authors:  Mehtap Cakir
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

2.  Autoimmune thyroid disease elicited by NY-ESO-1 vaccination.

Authors:  Roberto Vita; Fabrizio Guarneri; Ravin Agah; Salvatore Benvenga
Journal:  Thyroid       Date:  2013-07-25       Impact factor: 6.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.